Dermata Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 13.22 K | $231 | 2.78% | 0.26% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 12.00 K | $12.96 K | 0.00% | 0.23% |
| UBS GROUP AG | 05/13/2025 | 2.62 K | $44 | -36.82% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dermata Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Dermata Therapeutics, Inc.. The most heavily invested institutionals were:
TWO SIGMA SECURITIES, LLC: 13,215
BOOTHBAY FUND MANAGEMENT, LLC: 12,000
UBS Group AG: 2,617
ARMISTICE CAPITAL, LLC: 0
BANK OF AMERICA CORP /DE/: 0
Empery Asset Management, LP: 175,000
0.54% of Dermata Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 202.83 K shares in the last 24 months. This purchase volume represents approximately $4.06 K in transactions.